Erin M Davis1, Jennifer D Peck2, Karl R Hansen3, Barbara R Neas2, LaTasha B Craig3. 1. Department of Anatomical Sciences and Neurobiology, University of Louisville, Louisville, KY, USA - erin.davis@louisville.edu. 2. Department of Biostatistics and Epidemiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. 3. , Section of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Abstract
BACKGROUND: Studies comparing serum 25-hydroxyvitamin D concentrations in women with and without polycystic ovary syndrome (PCOS) have produced inconsistent results. Additionally, no previous studies have evaluated associations between vitamin D and specific PCOS phenotypes. METHODS: This case-control study was conducted among women undergoing intrauterine insemination. Cases (N.=137) were diagnosed with PCOS and then further classified into 3 diagnostic phenotypes based on combinations of the Rotterdam criteria (ovulatory dysfunction+polycystic ovaries [N.=55]; ovulatory dysfunction +androgen excess [N.=15]; and ovulatory dysfunction, +polycystic ovaries, +androgen excess [N.=67]). Controls (N.=103) were ovulatory women without PCOS who were undergoing IUI. Serum total 25-hydroxyvitamin D concentrations were categorized as deficient (≤20 ng/mL), insufficient (21-29 ng/mL), and sufficient (≥30 ng/mL). Prevalence odds ratios (PORs) were calculated using logistic regression. RESULTS: A higher proportion (59.9%) of PCOS cases lacked sufficient vitamin D levels compared to controls (47.6%; P value=0.06). The odds of vitamin D deficiency in all PCOS cases were twice that of controls (POR=2.03, 95% CI 0.97-4.26); however, the association was attenuated after adjusting for Body Mass Index (BMI) and race/ethnicity (adjPOR=1.43, 95% CI 0.62, 3.26). When examining PCOS phenotypes exhibiting androgen excess, crude associations were observed for deficient vitamin D levels (unadjPOR=2.93, 95% CI: 1.27, 6.77); however, the association decreased after adjustment for BMI and race/ethnicity (adjPOR=2.03, 95% CI: 0.79, 5.19). CONCLUSIONS: Vitamin D deficiency occurred more frequently in PCOS cases with androgen excess, but associations were attenuated after adjusting for BMI and race/ethnicity. Combining etiologically distinct PCOS subgroups may obscure associations with lower vitamin D levels and other potential risk factors.
BACKGROUND: Studies comparing serum 25-hydroxyvitamin D concentrations in women with and without polycystic ovary syndrome (PCOS) have produced inconsistent results. Additionally, no previous studies have evaluated associations between vitamin D and specific PCOS phenotypes. METHODS: This case-control study was conducted among women undergoing intrauterine insemination. Cases (N.=137) were diagnosed with PCOS and then further classified into 3 diagnostic phenotypes based on combinations of the Rotterdam criteria (ovulatory dysfunction+polycystic ovaries [N.=55]; ovulatory dysfunction +androgen excess [N.=15]; and ovulatory dysfunction, +polycystic ovaries, +androgen excess [N.=67]). Controls (N.=103) were ovulatory women without PCOS who were undergoing IUI. Serum total 25-hydroxyvitamin D concentrations were categorized as deficient (≤20 ng/mL), insufficient (21-29 ng/mL), and sufficient (≥30 ng/mL). Prevalence odds ratios (PORs) were calculated using logistic regression. RESULTS: A higher proportion (59.9%) of PCOS cases lacked sufficient vitamin D levels compared to controls (47.6%; P value=0.06). The odds of vitamin Ddeficiency in all PCOS cases were twice that of controls (POR=2.03, 95% CI 0.97-4.26); however, the association was attenuated after adjusting for Body Mass Index (BMI) and race/ethnicity (adjPOR=1.43, 95% CI 0.62, 3.26). When examining PCOS phenotypes exhibiting androgen excess, crude associations were observed for deficient vitamin D levels (unadjPOR=2.93, 95% CI: 1.27, 6.77); however, the association decreased after adjustment for BMI and race/ethnicity (adjPOR=2.03, 95% CI: 0.79, 5.19). CONCLUSIONS:Vitamin Ddeficiency occurred more frequently in PCOS cases with androgen excess, but associations were attenuated after adjusting for BMI and race/ethnicity. Combining etiologically distinct PCOS subgroups may obscure associations with lower vitamin D levels and other potential risk factors.
Authors: R Azziz; D Ehrmann; R S Legro; R W Whitcomb; R Hanley; A G Fereshetian; M O'Keefe; M N Ghazzi Journal: J Clin Endocrinol Metab Date: 2001-04 Impact factor: 5.958
Authors: Diana L Ersfeld; D Sudhaker Rao; Jean-Jacques Body; James L Sackrison; Andrew B Miller; Nayana Parikh; Tar Lisha Eskridge; Amy Polinske; Gregory T Olson; Gordon D MacFarlane Journal: Clin Biochem Date: 2004-10 Impact factor: 3.281
Authors: Chang Shan; Yu-Chen Zhu; Jie Yu; Yi Zhang; Yu-Ying Wang; Nan Lu; Jie Cai; Wei Liu; Tao Tao Journal: Front Endocrinol (Lausanne) Date: 2022-05-02 Impact factor: 6.055
Authors: K Lajtai; R Tarszabó; B Bányai; B Péterffy; D Gerszi; É Ruisanchez; R E Sziva; Á Korsós-Novák; R Benkő; L Hadjadj; Z Benyó; E M Horváth; G Masszi; S Várbíró Journal: Oxid Med Cell Longev Date: 2021-03-18 Impact factor: 6.543
Authors: Giuseppe Morgante; Ilenia Darino; Amelia Spanò; Stefano Luisi; Alice Luddi; Paola Piomboni; Laura Governini; Vincenzo De Leo Journal: J Clin Med Date: 2022-08-02 Impact factor: 4.964
Authors: Krisztina Lajtai; Csilla Terézia Nagy; Róbert Tarszabó; Rita Benkő; Leila Hadjadj; Réka Eszter Sziva; Dóra Gerszi; Bálint Bányai; Péter Ferdinandy; György László Nádasy; Zoltán Giricz; Eszter Mária Horváth; Szabolcs Várbíró Journal: Biomolecules Date: 2019-09-10